Advertisement
Advertisement
U.S. markets closed
Advertisement
Advertisement
Advertisement
Advertisement

CanaQuest Medical Corp. (CANQF)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
0.30000.0000 (0.00%)
At close: 09:59AM EST
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close0.3000
Open0.2000
Bid0.0000 x 0
Ask0.0000 x 0
Day's Range0.2000 - 0.3000
52 Week Range0.0201 - 0.4400
Volume1,100
Avg. Volume1,389
Market Cap6.041M
Beta (5Y Monthly)4.05
PE Ratio (TTM)N/A
EPS (TTM)-0.0600
Earnings DateDec 07, 2021 - Dec 13, 2021
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est0.78
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
N/A

Subscribe to Yahoo Finance Plus to view Fair Value for CANQF

Learn more
View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • CANAQUEST MEDICAL CORPORATION
    Analyst Report: DocuSign, Inc.DocuSign offers the Agreement Cloud, a broad cloud-based software suite that enables users to automate the agreement process and provide legally binding e-signatures from nearly any device. The company was founded in 2003 and completed its IPO in May 2018.
    Rating
    Fair Value
    Economic Moat
    3 days agoMorningstar
View more
  • ACCESSWIRE

    CanaQuest Files International Mentanine(R) Patent, a Scientific CBD Formulation for Mental Health

    TORONTO, ON / ACCESSWIRE / April 29, 2021 / CANAQUEST MEDICAL CORP (OTC PINK:CANQF) (the "Company" or "CanaQuest"), an award-winning Life Science/Pharmaceutical company developing formulations combining cannabinoid molecules with pharmaceutical-grade botanical compounds, today announced the filing of its International Patent, trade named Mentanine®, which has demonstrated at least 10-times (10X) the efficacy compared to Pharma Grade CBD.Mentanine® - an International CBD Excellence Award 2020 formulation was scientifically developed through preclinical trials at Western University.

  • ACCESSWIRE

    CanaQuest Medical Corp Appoints Investor Relations and PR Veteran Rob Rinderman as its New Director of Communications

    TORONTO, ON / ACCESSWIRE / April 7, 2021 / CANAQUEST MEDICAL CORP (OTC PINK:CANQF) (the "Company" or "CanaQuest"), an award-winning Life Science/Pharmaceutical company developing health and wellness products combining cannabinoid molecules with pharmaceutical-grade botanical compounds, today announced that Rob Rinderman has joined CanaQuest as its new Director of Communications. Rinderman will focus on managing a proactive investor relations and corporate communications program, further expanding investor community and media awareness about the company's material corporate developments and future prospects.

  • ACCESSWIRE

    CanaQuest Medical Corp Honored With International CBD Life Science R & D Excellence Award 2020 by Global Health & Pharma

    TORONTO, ON / ACCESSWIRE / March 29, 2021 / CANAQUEST MEDICAL CORP (OTC PINK:CANQF) (the "Company" or "CanaQuest"), a Life Science/Pharmaceutical Company developing health products utilizing cannabinoid molecules and other botanical compounds (pharmaceutical grade), today announced it has been awarded the International CBD Life Science R & D Excellence Award 2020 by Global Health & Pharma, United Kingdom, a global information sharing platform & multi-disciplinary members community.About Global Health & Pharma Awards:When it comes to handing out recognition and awards, we believe there are few more deserving than those whose dedication changes the lives of millions of people every day.

Advertisement
Advertisement